Stray proteins cause genetic disorders

September 6, 2018, Max Delbrück Center for Molecular Medicine
The Glut1 protein molecules (green) appears mainly in the interior of the induced pluripotent stem cells derived from a patient. Credit: Katrina Meyer, MDC

The seizures typically begin in the first months of life. It often takes years, however, before those suffering from the rare glucose transporter type 1 (Glut1) deficiency syndrome obtain a correct diagnosis. If the disorder goes untreated, affected children experience developmental delay and frequently have neurological problems. Various defects in one gene underlie the syndrome. They cause the Glut1 protein to lose its function in the cell membrane: the protein no longer transports glucose from the blood into the brain.

Miniscule changes in previously little-noticed flexible segments of the Glut1 protein could lead to severe cellular disturbances—other genetic disorders might be caused by the same mechanism. These are the findings of a study led by Professor Matthias Selbach of the Max Delbrück Center for Molecular Medicine (MDC) and published in the current issue of the journal Cell.

A fundamental problem

Selbach's team wanted to answer a basic question: How do defective genes cause diseases? Within the Glut1 gene, there are many places where a mutation can disrupt the Glut1 protein's three-dimensional structure, leading to loss of function. Malformed and contorted, the protein can no longer carry out its task in the cellular machinery and thus triggers the syndrome. The same process is at work in most genetically determined disorders. "But the mechanism involved in genetically determined diseases—or, in other words, the cause at the molecular level—is often unclear," says Katrina Meyer, a doctoral student in Selbach's lab.

In one-fifth of all genetic diseases, according to the scientist, the doesn't appear to be damaged at all. In such cases, she says, the mutation occurs in flexible loops in the proteins, which until recently were thought to have no function because they lack a defined structure. But appearances can be deceiving: "These so-called intrinsically disordered regions (IDRs) can snuggle up to other proteins as if they were soft pillows, thereby manipulate them."

Many cellular processes are based on such interactions between proteins. The molecules interlock with each other like cogs, transfer energy, or move levers and conveyor belt systems. Even a single protein in the wrong place can have drastic consequences. Meyer therefore began by looking into which of the cell's proteins come into contact with flexible mutated protein regions.

Katrina Meyer is punching samples from a membrane with artificial protein fragments. Credit: Martin Ballaschk, MDC

Subtle change with a big impact

The doctoral student did this by recreating 258 flexible protein regions in test tubes—both "healthy" variants as well as disease-related ones—and then adding human cell extracts. The next step involved using mass spectrometry to determine which proteins interact with the artificial proteins.

In Meyer's experiment the mutated and "healthy" regions mostly docked onto the same binding partners. But some of the mutated proteins completely lost this ability or bound to other proteins and thus disrupted the operation of the cellular machinery. Some genetic changes even affect intracellular protein transport through this process. An example is a mutation in the gene for the Glut1 protein that causes two specific building blocks of protein, namely leucines, to lie next to one another, creating a so-called dileucine motif. "This pattern is known to attract proteins that aid the cell in transporting other proteins inside its interior," says Meyer.

Right protein, wrong place

It was a special moment when Meyer made this discovery. Could it be that in people affected by this mutation the Glut1 protein is not defective but has instead ended up in the wrong place in the cell? "If the protein itself is not affected but only the transport function, there is a chance that the underlying cause can be treated—not just the symptom," explains Meyer.

She searched databases and found a patient with Glut1 deficiency syndrome in whom the protein region contained a mutation creating the dileucine motif. The patient donated cells to her. In tests on cell cultures Meyer showed that the mutated Glut1 protein was no longer present on the cell surface, where it takes up glucose. The protein was instead in the cell's interior as if it had gotten lost.

Close-up of a mass spectrometer which was used to identify the proteins that bind to mutated disordered protein regions. Credit: David Ausserhofer / MDC

The cellular apparatus involved in pinching off vesicles from the cell membranes and transporting them into the cell's interior via endocytosis is partially responsible for misrouting the Glut1 protein. Meyer was able to confirm her hypothesis: When she blocked this process, the Glut1 protein found its way back to the cell surface and resumed glucose uptake. "This could theoretically be blocked by medications," says Meyer.

A new mechanism for numerous diseases

These medications don't exist yet, says Matthias Selbach, head of the laboratory, but the discovery has implications beyond Glut1. By searching databases, the research team found the dileucine motif eleven times in the flexible regions of eight proteins, including in the protein that triggers the metabolic disorder cystic fibrosis.

"We have identified a promising target against a wide range of diseases," says Selbach. "I see considerable potential here for developing new medications." Future studies will need to determine whether these diseases can be systematically fought with endocytosis blockers.

Even though it often takes years for people affected by Glut1 deficiency syndrome to be correctly diagnosed, says Selbach, it is now relatively well treatable. Pasta, bread, and ice cream, however, are off limits to patients. They must follow a strict ketogenic diet, which involves avoiding foods that contain sugar and starch. Such a regimen usually causes the seizures to stop because the brain cells receive their energy from a different source. "But the disorder remains incurable," says Selbach. "And patients must drastically restrict their diet."

Explore further: Blood test can detect GLUT1 deficiency syndrome

More information: Cell (2018). DOI: 10.1016/j.cell.2018.08.019

Related Stories

Blood test can detect GLUT1 deficiency syndrome

June 23, 2017
(HealthDay)—A simple and rapid blood test can detect GLUT1 deficiency syndrome (DS), according to a study published online May 26 in the Annals of Neurology.

Scientists find cellular mechanism for how the body regulates glucose transport

June 9, 2015
UT Southwestern Medical Center scientists have gleaned a key cellular mechanism of how the body adjusts glucose levels, an important process that when abnormal can promote diabetes, cancer, and rare genetic diseases.

Cancer protein could point to new targets for treatment

April 13, 2018
A new view of a protein frequently mutated in pituitary tumors is overturning conventional wisdom and could point to novel targets for cancer drugs.

Recommended for you

Researchers identify a new cause of childhood mitochondrial disease

September 20, 2018
A rapid genetic test developed by Newcastle researchers has identified the first patients with inherited mutations in a new disease gene.

Test could detect patients at risk from lethal fungal spores

September 20, 2018
Scientists at The University of Manchester have discovered a genetic mutation in humans linked to a 17-fold increase in the amount of dangerous fungal spores in the lungs.

Why some human genes are more popular with researchers than others

September 18, 2018
Historical bias is a key reason why biomedical researchers continue to study the same 10 percent of all human genes while ignoring many genes known to play roles in disease, according to a study publishing September 18 in ...

Class of neurological disorders share 3-D genome folding pattern, study finds

September 18, 2018
In a class of roughly 30 neurological disorders that includes ALS, Huntington's Disease and Fragile X Syndrome, the relevant mutant gene features sections of repeating base pair sequences known as short tandem repeats, or ...

Researchers resolve decades-old mystery about the most commonly mutated gene in cancer

September 18, 2018
The most commonly mutated gene in cancer has tantalized scientists for decades about the message of its mutations. Although mutations can occur at more than 1,100 sites within the TP53 gene, they arise with greatest frequency ...

Study of one million people leads to world's biggest advance in blood pressure genetics

September 17, 2018
Over 500 new gene regions that influence people's blood pressure have been discovered in the largest global genetic study of blood pressure to date, led by Queen Mary University of London and Imperial College London.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

sherryyyyy1111
not rated yet Sep 10, 2018
In order to know more about proteins, it would be good to use label free quantitative proteomics method. creative proteomics are willing to offer you the efficient method to learn more about stray proteins related genetic disorders

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.